1-3 of 3
Ann Dahlberg
Close
Sort by
Journal Articles

Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipients

Clinical Trials & Observations
Joshua A. Hill, Danniel Zamora, Hu Xie, Laurel A. Thur, Colleen Delaney, Ann Dahlberg, Steven A. Pergam, Wendy M. Leisenring, Michael Boeckh, Filippo Milano
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3113–3119.
https://doi.org/10.1182/bloodadvances.2021004362
Published: 2021
Includes: Supplemental data
Journal Articles

Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study

Clinical Trials & Observations
Filippo Milano, Jonathan A. Gutman, H. Joachim Deeg, Eneida R. Nemecek, Joachim Baumgart, Laurel Thur, Ann Dahlberg, Rachel B. Salit, Corinne Summers, Frederick R. Appelbaum, Colleen Delaney
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3302–3310.
https://doi.org/10.1182/bloodadvances.2020002222
Published: 2020
Includes: Supplemental data
Journal Articles

The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia

Clinical Trials & Observations
Amy K. Keating, Jurgen Langenhorst, John E. Wagner, Kristin M. Page, Paul Veys, Robert F. Wynn, Heather Stefanski, Reem Elfeky, Roger Giller, Richard Mitchell, Filippo Milano, Tracey A. O'Brien, Ann Dahlberg, Colleen Delaney, Joanne Kurtzberg, Michael R. Verneris, Jaap Jan Boelens
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1118–1128.
https://doi.org/10.1182/bloodadvances.2018025908
Published: 2019